Mohamed Abousenna

Dr
Mohamed
Abousenna

Associate Professor
Central Laboratory for Evaluation of Veterinary Biologics, Cairo, Egypt.
Biography
**Dr. Mohamed Samy Mohamed Abousenna: A Leading Virologist in Veterinary Vaccine Development and Biosafety** Dr. Mohamed Samy Mohamed Abousenna is an accomplished Associate Professor of Virology and a Senior Researcher at the Central Laboratories for Evaluation of Veterinary Biologics (CLEVB) in Abbassia, Cairo, Egypt. With a career dedicated to the study of virology, vaccine development, and biosafety, Dr. Abousenna has established himself as a prominent figure in the field of veterinary medicine, particularly in the fight against transboundary animal diseases such as Foot-and-Mouth Disease (FMD). ### **Academic and Professional Background** Dr. Abousenna’s academic journey began with a Bachelor of Veterinary Medicine from Cairo University in 2006, followed by a Diploma in Microbiology from the same institution in 2009. He further pursued a Master’s degree in Virology from Benha University in 2012, focusing on alternative methods for evaluating live attenuated Respiratory Syncytial Virus vaccines. His doctoral studies, completed in 2016, centered on inactivated vaccines for Foot-and-Mouth Disease Virus (FMDV), solidifying his expertise in virology and vaccine development. As a Senior Researcher at CLEVB, Dr. Abousenna has been instrumental in the quality control of viral vaccines for both large and pet animals, including FMDV, Rift Valley Fever Virus (RVFV), Rabies, Bovine Respiratory Syncytial Virus (BRSV), and more. His work spans the entire vaccine production process, from upstream cell isolation and cultivation to downstream purification and final product polishing. He is also deeply involved in vaccine matching, serological testing, molecular biology, and the isolation and identification of field viral isolates. ### **International Recognition and Contributions** Dr. Abousenna’s expertise has earned him a place on the roster of the European Commission for the Control of Foot-and-Mouth Disease (EuFMD) Technical Specialists, a testament to his specialized knowledge in FMD and similar transboundary animal diseases. His contributions extend beyond Egypt, as he has participated in numerous international training programs, workshops, and conferences, including those organized by the USDA, FAO, and various universities across the globe. Notably, Dr. Abousenna has been involved in international collaborations and research projects, such as the development of lateral flow devices for the rapid detection of antibodies against Rift Valley Fever Virus and COVID-19. His work on these projects has been funded by prestigious organizations like CRDF Global and the Science and Technology Development Fund (STDF) in Egypt. ### **Research and Publications** Dr. Abousenna’s research interests are vast and impactful, focusing on filling gaps in vaccine production and vaccination strategies for viral endemic diseases. He is particularly interested in developing alternative methods for vaccine evaluation, novel diagnostic techniques, and approaches to enhance biosafety in laboratory and animal facilities. His extensive list of publications reflects his commitment to advancing the field of virology. Some of his notable works include studies on the humoral response of cattle to FMD vaccines, the development of lateral flow kits for rapid virus detection, and the evaluation of vaccines against emerging viral strains. His research has been published in reputable journals such as *PLoS One*, *Veterinary Medicine and Science*, and *Scientific Reports*. ### **Training and Workshops** Dr. Abousenna’s dedication to continuous learning and professional development is evident in his participation in numerous training programs and workshops. He has received training in quality assurance, biosafety, biosecurity, and the implementation of ISO/IEC 17025 standards. His international training includes programs in the United States, Germany, South Africa, and China, where he gained valuable insights into biocontainment, biorisk management, and veterinary biologics. ### **Professional Memberships and Awards** Dr. Abousenna is an active member of several professional associations, including the World Society for Virology, the US Animal Vaccinology Research Coordination Network, and the International Veterinary Vaccinology Network. He is also a member of the American Society for Microbiology and the Egyptian Society of Virology. His contributions to the field have been recognized with awards, including the USDA ARS 7th International Symposium Student and Young Professional Poster Award in 2023. ### **Future Directions** Dr. Abousenna continues to push the boundaries of virology and vaccine development. His ongoing research projects include the development of lateral flow immunoassays for the detection of antibodies against H5N1 avian influenza in cattle milk and serum, as well as the evaluation of bioactive nanomaterials for enhancing FMD vaccination efficacy. His work not only addresses current challenges in veterinary medicine but also paves the way for innovative solutions to prevent and control viral diseases in animals. ### **Conclusion** Dr. Mohamed Samy Mohamed Abousenna is a distinguished virologist whose work has significantly contributed to the field of veterinary vaccine development and biosafety. His extensive research, international collaborations, and commitment to professional development have made him a respected figure in the global fight against transboundary animal diseases. As he continues to explore new frontiers in virology, Dr. Abousenna’s work promises to have a lasting impact on animal health and disease prevention worldwide. For more information on Dr. Abousenna’s research and publications, visit his profiles on [ResearchGate](https://www.researchgate.net/profile/Mohamed_Abousenna2), [ORCID](https://orcid.org/0000-0003-2202-9544), and [Google Scholar](https://scholar.google.com/citations?view_op=list_works&hl=en&user=j213xQYAAAAJ).
Research interests

- Filling research gap for Vaccine production and Vaccination strategy for viral endemic diseases. - Development of alternative methods for vaccine evaluation. - Development of Novel techniques for diagnosis of viruses. - Studying and development approaches which serve Biosafety in Laboratory and animal facility.

Discipline
Bioinformatics Challenge study design Clinical trials – efficacy Clinical trials – safety Deployment Virology
Host species
Cats Cattle Dogs Horses Small ruminants
Pathogen
Viruses VirusesBluetongue virus VirusesBovine ephemeral fever virus VirusesBovine viral diarrhoea VirusesCapripoxvirus VirusesFoot-and-mouth disease virus VirusesPoxviruses VirusesRabies virus VirusesRespiratory syncytial virus VirusesRift Valley fever virus
Stage of vaccine development
Clinical trials Correlates of protection – immunomonitoring